Iodine determination in photographic fixers by energy-dispersive X-ray fluorescenceMORSE, M. A.X-ray spectrometry. 1992, Vol 21, Num 2, pp 99-102, issn 0049-8246Article

Chlorine determination in photographic developer solutions using wavelength-dispersive X-ray fluorescenceMORSE, M. A.X-ray spectrometry. 1994, Vol 23, Num 5, pp 218-220, issn 0049-8246Article

High-performance liquid chromatographic method for measurement of cytochrome P450-mediated metabolism of 7-ethoxy-4-trifluoromethylcoumarinMORSE, M. A; LU, J.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 708, Num 1-2, pp 290-293, issn 1387-2273Article

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancerAGGARWAL, C; MEROPOL, N. J; MILLER, M. C et al.Annals of oncology. 2013, Vol 24, Num 2, pp 420-428, issn 0923-7534, 9 p.Article

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibodyOSADA, T; HSU, D; HAMMOND, S et al.British journal of cancer. 2010, Vol 102, Num 1, pp 124-133, issn 0007-0920, 10 p.Article

Effects of 10-hydroxycamptothecin, delivered from locally injectable poly(lactide-co-glycolide) microspheres, in a murine human oral squamous cell carcinoma regression modelMALLERY, S. R; SHENDEROVA, A; PEI, P et al.Anticancer research. 2001, Vol 21, Num 3B, pp 1713-1722, issn 0250-7005Article

Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancerSTONER, G. D; MORSE, M. A.Cancer letters. 1997, Vol 114, Num 1-2, pp 113-119, issn 0304-3835Conference Paper

Inhibition of metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by limoneneMORSE, M. A; TOBUREN, A. L.Cancer letters. 1996, Vol 104, Num 2, pp 211-218, issn 0304-3835, 7 p.Article

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in the lung of F344 rats by dietary phenethyl isothiocyanateMORSE, M. A; CHUNG-XIOU WANG; STONER, G. D et al.Cancer research (Baltimore). 1989, Vol 49, Num 3, pp 549-553, issn 0008-5472Article

A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigenMORSE, M. A; YUPING DENG; COLEMAN, D et al.Clinical cancer research. 1999, Vol 5, Num 6, pp 1331-1338, issn 1078-0432Article

Expression of cytochrome P450 2A3 in rat esophagus : Relevance to n-nitrosobenzylmethylamineGOPALAKRISHNAN, R; MORSE, M. A; LU, J et al.Carcinogenesis (New York. Print). 1999, Vol 20, Num 5, pp 885-891, issn 0143-3334Article

Enhancement of esophageal carcinogenesis in male F344 rats by dietary phenylhexyl isothiocyanateSTONER, G. D; SIGLIN, J. C; MORSE, M. A et al.Carcinogenesis (New York. Print). 1995, Vol 16, Num 10, pp 2473-2476, issn 0143-3334Article

The effects of phenethyl isothiocyanate on benzo[a]pyrene-induced tumors and DNA adducts in A/J mouse lungADAM-RODWALL, G; MORSE, M. A; STONER, G. D et al.Cancer letters. 1993, Vol 71, Num 1-3, pp 35-42, issn 0304-3835Article

Cancer chemoprevention : principles and prospectsMORSE, M. A; STONER, G. D.Carcinogenesis (New York. Print). 1993, Vol 14, Num 9, pp 1737-1746, issn 0143-3334Article

Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J miceMORSE, M. A; EKLIND, K. I; AMIN, S. G et al.Cancer letters. 1992, Vol 62, Num 1, pp 77-81, issn 0304-3835Article

Effect of dietary aromatic isothiocyanates fed subsequent to the administration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumorigenicity in miceMORSE, M. A; REINHARDT, J. C; AMIN, S. G et al.Cancer letters. 1990, Vol 49, Num 3, pp 225-230, issn 0304-3835Article

ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancersSINNATHAMBY, G; ZERFASS, J; HAFNER, J et al.Clinical and experimental immunology (Print). 2011, Vol 163, Num 3, pp 324-332, issn 0009-9104, 9 p.Article

Migration of human dendritic cells after injection in patients with metastatic malignanciesMORSE, M. A; COLEMAN, R. E; AKABANI, G et al.Cancer research (Baltimore). 1999, Vol 59, Num 1, pp 56-58, issn 0008-5472Article

Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancerSTONER, G. D; KRESTY, L. A; CARLTON, P. S et al.Toxicological sciences (Print). 1999, Vol 52, Num 2, pp 95-100, issn 1096-6080, SUPConference Paper

Mechanism of enhancement of esophageal tumorigenesis by 6-phenylhexyl isothiocyanateMORSE, M. A; LU, J; GOPALAKRISHNAN, R et al.Cancer letters. 1997, Vol 112, Num 1, pp 119-125, issn 0304-3835Article

Dose-related inhibition by dietary phenethyl isothiocyanate of esophageal tumorigenesis and DNA methylation induced by N-nitrosomethylbenzylamine in ratsMORSE, M. A; HONGXIANG ZU; GALATI, A. J et al.Cancer letters. 1993, Vol 72, Num 1-2, pp 103-110, issn 0304-3835Article

Influence of splanchnic intravascular volume changes on cardiac output during muscarinic receptor stimulation in the anaesthetized dogMORSE, M. A; BELL, L; RUTLEN, D. L et al.Acta physiologica scandinavica. 1990, Vol 138, Num 3, pp 331-336, issn 0001-6772Article

Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanatesSMITH, T. J; ZUYU GUO; THOMAS, P. E et al.Cancer research (Baltimore). 1990, Vol 50, Num 21, pp 6817-6822, issn 0008-5472, 6 p.Article

Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEANAIR, S. K; HULL, S; COLEMAN, D et al.International journal of cancer. 1999, Vol 82, Num 1, pp 121-124, issn 0020-7136Article

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-α for use in cancer immunotherapyMORSE, M. A; ZHOU, L.-J; TEDDER, T. F et al.Annals of surgery. 1997, Vol 226, Num 1, pp 6-16, issn 0003-4932Article